NCT03172156View on ClinicalTrials.gov

ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
Non-small Cell Lung Cancer Stage I
Interventions
GENETIC

ctDNA detection

To detect ctDNA in Patients With Stage I Non-small Cell Lung Cancer (NSCLC) Using Secondary Gene Sequencing (NGS)

Trial Locations (1)

510060

Si-Yu Wang, Guangzhou

All Listed Sponsors
collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

lead

Sun Yat-sen University

OTHER

NCT03172156 - ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS | Biotech Hunter | Biotech Hunter